{"altmetric_id":2523500,"counts":{"readers":{"mendeley":8,"citeulike":0,"connotea":0},"total":{"posts_count":2},"twitter":{"unique_users_count":2,"unique_users":["BTumour_fighter","NeuroOnc"],"posts_count":2}},"selected_quotes":["FREE Neuro-Onc Art: Methylated RASSF1A in malig. peripheral nerve sheath tumor identify neurofibromatosis type 1 pts"],"citation":{"abstract":"Malignant peripheral nerve sheath tumor (MPNST) is a rare and highly aggressive disease with no evidence of effect from adjuvant therapy. It is further associated with the hereditary syndrome neurofibromatosis type 1 (NF1). Silencing of the tumor suppressor gene RASSF1A through DNA promoter hypermethylation is known to be involved in cancer development, but its impact in MPNSTs remains unsettled.","abstract_source":"pubmed","altmetric_jid":"4f6fa62f3cf058f61000828a","authors":["Stine A. Danielsen","Guro E. Lind","Matthias Kolberg","Maren H\u00f8land","Bodil Bjerkehagen","Kirsten Sundby Hall","Eva van den Berg","Fredrik Mertens","Sigbj\u00f8rn Smeland","Piero Picci","Ragnhild A. Lothe","Danielsen SA","Lind GE","Kolberg M","H\u00f8land M","Bjerkehagen B","Sundby Hall K","van den Berg E","Mertens F","Smeland S","Picci P","Lothe RA","S. A. Danielsen","G. E. Lind","M. Kolberg","M. Holand","B. Bjerkehagen","K. Sundby Hall","E. van den Berg","F. Mertens","S. Smeland","P. Picci","R. A. Lothe"],"doi":"10.1093\/neuonc\/nou140","endpage":"69","first_seen_on":"2014-07-20T01:38:56+00:00","issns":["1523-5866","1522-8517"],"issue":"1","journal":"Neuro-Oncology","last_mentioned_on":1421875227,"links":["http:\/\/neuro-oncology.oxfordjournals.org\/content\/early\/2014\/07\/18\/neuonc.nou140.short?rss=1","http:\/\/neuro-oncology.oxfordjournals.org\/content\/17\/1\/63.abstract"],"pdf_url":"http:\/\/neuro-oncology.oxfordjournals.org\/content\/early\/2014\/07\/18\/neuonc.nou140.full.pdf","pmid":"25038505","pubdate":"2014-07-18T23:00:00+00:00","publisher_subjects":[{"name":"Neurosciences","scheme":"era"},{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"63","subjects":["neoplasms","neurology"],"title":"Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis","type":"article","uri":"http:\/\/neuro-oncology.oxfordjournals.org\/cgi\/doi\/10.1093\/neuonc\/nou140","volume":"17","mendeley_url":"http:\/\/www.mendeley.com\/research\/methylated-rassf1a-malignant-peripheral-nerve-sheath-tumors-identifies-neurofibromatosis-type-1-pati-1"},"altmetric_score":{"score":1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":4763379,"mean":5.4984634704477,"rank":2463531,"this_scored_higher_than_pct":35,"this_scored_higher_than":1671022,"rank_type":"exact","sample_size":4763379,"percentile":35},"similar_age_3m":{"total_number_of_other_articles":112638,"mean":8.3334727664978,"rank":56400,"this_scored_higher_than_pct":37,"this_scored_higher_than":42057,"rank_type":"exact","sample_size":112638,"percentile":37},"this_journal":{"total_number_of_other_articles":1010,"mean":2.5034271555996,"rank":459,"this_scored_higher_than_pct":41,"this_scored_higher_than":420,"rank_type":"exact","sample_size":1010,"percentile":41},"similar_age_this_journal_3m":{"total_number_of_other_articles":61,"mean":1.165,"rank":18,"this_scored_higher_than_pct":59,"this_scored_higher_than":36,"rank_type":"exact","sample_size":61,"percentile":59}}},"demographics":{"poster_types":{"member_of_the_public":1,"science_communicator":1},"users":{"twitter":{"cohorts":{"Members of the public":1,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Researcher":1,"Student  > Ph. D. Student":3,"Student  > Master":2,"Student  > Bachelor":2},"by_discipline":{"Medicine and Dentistry":2,"Psychology":1,"Agricultural and Biological Sciences":5}}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/BTumour_fighter\/status\/490671951216513024","license":"datasift","citation_ids":[2523500],"posted_on":"2014-07-20T01:38:04+00:00","author":{"name":"Ale C.","image":"https:\/\/pbs.twimg.com\/profile_images\/456317179055460352\/ZeLNx979_normal.jpeg","description":"Dx: Astrocytoma grade II (1997). After 17 years I'm still here, fighting my disease like the very 1st day. Sharing info about #BrainTumour . Welcome! :)","id_on_source":"BTumour_fighter","tweeter_id":"377932657","geo":{"lt":null,"ln":null},"followers":537},"tweet_id":"490671951216513024"},{"url":"https:\/\/twitter.com\/NeuroOnc\/status\/558011264900014080","license":"datasift","citation_ids":[2523500],"posted_on":"2015-01-21T21:20:27+00:00","author":{"name":"SNO","url":"http:\/\/soc-neuro-onc.org","image":"https:\/\/pbs.twimg.com\/profile_images\/1533486907\/sno-logo_normal.jpg","description":"A multidisciplinary society of healthcare professionals dedicated to promoting advances in neuro-oncology through research and education.","id_on_source":"NeuroOnc","tweeter_id":"243643878","geo":{"lt":null,"ln":null},"followers":1533},"tweet_id":"558011264900014080"}]}}